FDA cleared the Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1) from Sienco, Inc. on Oct 27, 2026 under K260909, a special 510(k). The device falls under product code JPA, System, Multipurpose For In Vitro Coagulation Studies, regulated at 21 CFR 864.5425 as a Class 2 device. The review panel was Hematology.
FDA logged the submission as received on Mar 19, 2026. The decision came 222 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Sienco, Inc. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K260909?
K260909 is the FDA 510(k) for Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1), submitted by Sienco, Inc.. FDA's decision date was Oct 27, 2026, under product code JPA (System, Multipurpose For In Vitro Coagulation Studies).
Who makes the Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1)?
Sienco, Inc., based in Boulder, CO, is the applicant of record for K260909.
How long did the K260909 review take?
FDA received the submission on Mar 19, 2026 and issued its decision on Oct 27, 2026, 222 days later.